Open Access Platform Allows U-M Researchers To Explore Clinical Studies, 125M Patient Records
Researchers across Michigan Medicine may now request access to the ACT (Accrual to Clinical Trials) Network, which can be used to explore and validate feasibility for participating CTSA multi-site clinical studies using electronic health record data.
Using ACT, investigators can:
Explore patient populations in-depth, in real-time, from their desktop.
Confirm study feasibility by iteratively testing and refining inclusion and exclusion criteria.
Demonstrate study feasibility in funding proposals and IRB submissions.
Identify potential partners for multi-site studies by searching for patients across the CTSA network.
What is the ACT Network?
The ACT Network is a real-time, open-access platform allowing researchers throughout the CTSA consortium to explore and validate feasibility for clinical studies using electronic health record data. The ACT Network currently contains more than 125M patient records.
The ACT Network is open access and available to all researchers across the University of Michigan at no cost through the Michigan Institute for Clinical & Health Research (MICHR). To request access and learn more about ACT, go to actnetwork.us/MICHR.
ACT is NIH-funded and HIPAA-compliant. ACT was developed collaboratively by CTSA hubs (with funding from NCATS) to help investigators more efficiently develop and validate parameters for clinical studies.
As part of the implementation process, the ACT platform (and its governing agreements) have been reviewed for HIPAA compliance and approved by the IRB – no additional IRB approval is needed for researchers wishing to use ACT. (To learn more about how ACT protects patient confidentiality, see the ACT Network Governance and Regulatory information here.)
Visit actnetwork.us/MICHR to learn more and request access.